AIP and neoplasm: Similar to pituitary adenomas in humans that are associated with loss of function AIP mutations and display increased tumor invasion and poor response to somatostatin analog treatment, sAIPKO mice had pituitary adenomas that were aggressive and treatment-resistant (45).